Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
出版年份 2021 全文链接
标题
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-07-22
DOI
10.1016/j.annonc.2021.07.006
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
- (2021) Carol J. Swallow et al. ANNALS OF SURGICAL ONCOLOGY
- Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
- (2020) Lorenzo D’Ambrosio et al. CANCER
- A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma
- (2020) Anusha Kalbasi et al. CLINICAL CANCER RESEARCH
- A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
- (2020) Nicolas Penel et al. EUROPEAN JOURNAL OF CANCER
- The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
- (2020) Ben Alman et al. EUROPEAN JOURNAL OF CANCER
- Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas
- (2020) Javier Martin-Broto et al. JAMA Oncology
- Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the sarcoma patients EuroNet
- (2020) Rick L. Haas et al. CANCER
- Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
- (2020) Thierry Frebourg et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis
- (2020) Dimitrios Nasioudis et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
- (2020) Alessandro Gronchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Selumetinib in Children with Inoperable Plexiform Neurofibromas
- (2020) Andrea M. Gross et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis
- (2020) Giacomo Giulio Baldi et al. ONCOLOGIST
- 1624MO Weekly nab-paclitaxel for progressive or symptomatic desmoid tumors: A multicenter single arm phase II trial from the Spanish Group for Research on Sarcoma (GEIS)
- (2020) J. Martin Broto et al. ANNALS OF ONCOLOGY
- Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status
- (2020) Olivier Mir et al. CLINICAL CANCER RESEARCH
- Activity and Safety of Geptanolimab (GB226) for patients with unresectable, recurrent or metastatic alveolar soft part sarcoma: a phase 2 single-arm study
- (2020) Yuankai Shi et al. CLINICAL CANCER RESEARCH
- Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
- (2020) Mrinal Gounder et al. LANCET ONCOLOGY
- Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
- (2020) Sylvie Bonvalot et al. LANCET ONCOLOGY
- Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma
- (2020) Jules Lansu et al. JAMA Oncology
- The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
- (2019) Sandro Pasquali et al. EUROPEAN JOURNAL OF CANCER
- Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
- (2019) Roberta Sanfilippo et al. CLINICAL CANCER RESEARCH
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
- (2019) William D Tap et al. LANCET
- Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
- (2019) Silvia Stacchiotti et al. LANCET ONCOLOGY
- Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
- (2019) Vaia Florou et al. Journal for ImmunoTherapy of Cancer
- Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
- (2019) F. G. M. Verspoor et al. Scientific Reports
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?
- (2018) Marco Fiore et al. ANNALS OF SURGICAL ONCOLOGY
- Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection
- (2018) Kenneth R. Gundle et al. JOURNAL OF CLINICAL ONCOLOGY
- Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
- (2018) Hans Gelderblom et al. LANCET ONCOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
- (2018) Patrick Schöffski et al. Lancet Respiratory Medicine
- Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma
- (2018) Rolf D. Issels et al. JAMA Oncology
- Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma
- (2018) Anna Maria Frezza et al. JAMA Oncology
- Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study
- (2018) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres
- (2018) Dario Callegaro et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial
- (2018) Javier Martin-Broto et al. LANCET ONCOLOGY
- Sorafenib for Advanced and Refractory Desmoid Tumors
- (2018) Mrinal M. Gounder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)
- (2017) Bernd Kasper et al. EUROPEAN JOURNAL OF CANCER
- YWHAE -rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy
- (2017) Matthew L. Hemming et al. GYNECOLOGIC ONCOLOGY
- Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
- (2017) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
- (2017) Beatrice Seddon et al. LANCET ONCOLOGY
- Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
- (2017) Gemma Gatta et al. LANCET ONCOLOGY
- Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
- (2016) A. Gronchi et al. ANNALS OF ONCOLOGY
- Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
- (2016) ANNALS OF SURGICAL ONCOLOGY
- Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting
- (2016) E. Wardelmann et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
- (2016) Patrick Schöffski et al. LANCET
- Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Olivier Mir et al. LANCET ONCOLOGY
- Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
- (2016) Dario Callegaro et al. LANCET ONCOLOGY
- Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide
- (2015) Elena Palassini et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of Regional Hyperthermia With Chemotherapy for High-Risk Retroperitoneal and Abdominal Soft-Tissue Sarcoma After Complete Surgical Resection
- (2014) Martin K. Angele et al. ANNALS OF SURGERY
- Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial
- (2014) Joal D. Beane et al. ANNALS OF SURGICAL ONCOLOGY
- What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients
- (2014) C Rothermundt et al. BRITISH JOURNAL OF CANCER
- Evaluating the Risks of Electric Uterine Morcellation
- (2014) Kimberly A. Kho et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hormonal Therapy for Aggressive Angiomyxoma
- (2014) Peter Edward Schwartz et al. Journal of Lower Genital Tract Disease
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- Sorafenib in patients with progressive epithelioid hemangioendothelioma
- (2013) Christine Chevreau et al. CANCER
- Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma
- (2013) Martee L. Hensley et al. CANCER
- Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-a-vis Temozolomide and Antiangiogenics
- (2013) S. Stacchiotti et al. CLINICAL CANCER RESEARCH
- Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets
- (2013) Alessandro Gronchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Sunitinib malate in solitary fibrous tumor (SFT)
- (2012) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions
- (2012) I. Ray-Coquard et al. ANNALS OF ONCOLOGY
- Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG
- (2012) Syvie Bonvalot et al. ANNALS OF SURGICAL ONCOLOGY
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
- (2012) Penella J Woll et al. LANCET ONCOLOGY
- 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
- (2012) C.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
- (2011) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential
- (2011) Philip P.C. Ip et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity
- (2011) Roi Dagan et al. CANCER
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
- (2011) Min S. Park et al. CANCER
- Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
- (2011) Jan P. Deroose et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
- (2011) Xavier García-del-Muro et al. JOURNAL OF CLINICAL ONCOLOGY
- Resection of Pulmonary and Extrapulmonary Sarcomatous Metastases Is Associated With Long-Term Survival
- (2009) Shanda H. Blackmon et al. ANNALS OF THORACIC SURGERY
- Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
- (2009) Anastasia Constantinidou et al. EUROPEAN JOURNAL OF CANCER
- Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
- (2008) N.S. Reed et al. EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
- (2008) Nicolas Penel et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started